No Data
Market Movements | Home Appliances stocks in Hong Kong are active, HISENSE HA is up by 4%, and the National Development and Reform Commission has intensified the old-for-new subsidy policy.
Hong Kong stocks in the Home Appliances sector were active in the morning. As of the time of writing, HISENSE HA is up 4%, HAIER SMARTHOME is up 2%, and Midea Group Co., Ltd is up 1%.
The warning from the U.S. health director caused a drop in Asian alcoholic beverage stocks.
①After the Director of the Health Bureau in the USA called for cancer warning labels on Alcoholic Beverages last Friday, the Stocks of Asian liquor manufacturers fell on Monday. ② Edward Mundy, an Analyst at Jefferies Financial, wrote that the market is adopting a "shoot first and ask questions later" strategy to deal with potential health warnings and cancer risk labels on Alcoholic Beverages in the USA.
Kweichow Moutai's 2024 performance has "initially submitted": annual growth exceeds 15%, and Moutai's base liquor has reduced production for the first time.
Response cycle.
Moutai liquor production cuts? Individuals close to Kweichow Moutai: last year's production remained within a normal and orderly Range | Quick read announcement.
In 2024, Kweichow Moutai plans to produce approximately 0.0563 million tons of Moutai liquor, a decrease of 1.58% year-on-year. Last year, increased marketing investments in the Moutai series of liquors and the higher proportion led to a decline in the company's overall net margin, which may have fallen below 50% last year, reaching the lowest level since 2018. Amid soft stock prices, Kweichow Moutai officially initiated a buyback, with nearly 0.3 billion yuan repurchased on the first day.
The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?
① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.
Policy stimulus for 3C and home appliance demand release. Will the multiplier effect of the "trade-in" policy continue in 2025? | Year-end review.
In 2024, the implementation of the "national subsidy" policy for the exchange of old for new will effectively stimulate the demand for home appliances and Consumer Electronics. Market analysis suggests that related subsidies for the exchange of old for new are expected to continue next year, with mobile phones and more home improvement categories likely included, while the future policy-driven effects still remain to be observed.